Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Progressive NK cell dysfunction/reduced cytotoxic activity and innate lymphoid cell (Lin-/CD127+) imbalance (increase in CRTH2+CD117⁻ ILC2, a subset linked to type 2 cytokine production) favors immune evasion in myeloma.”
Title: Progressive NK Cell Dysfunction and ILC Imbalance Favor Immune Evasion in Multiple Myeloma
Authors: Maria Teresa Bilotta, Antonio Giovanni Solimando, Vanessa Desantis, Lucia Di Marzo, Andrea Sabatini, Sergio Forcelloni, Alessandro Andriano, Arcangelo Morizio, Antonella Argentiero, Roberto Ria, Linda Quatrini, Lorenzo Moretta, Paola Vacca, Nicola Tumino
You can read the Full Article in Blood Advances.
You can find more posts featuring Robert Orlowski on OncoDaily.
